Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus OSMITROL 5 IN WATER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus OSMITROL 5 IN WATER.
OSMITROL 10% IN WATER vs OSMITROL 5% IN WATER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow, thereby enhancing water excretion.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular and interstitial spaces into the extracellular compartment, thereby reducing cerebral edema and intraocular pressure; also promotes diuresis by increasing renal tubular fluid osmolality.
0.25-2 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours as needed. Maximum dose: 2 g/kg per dose or 200 g daily.
50-100 g intravenously as a 5% solution over 30-60 minutes; may repeat every 6-8 hours as needed. Maximum dose: 200 g in 24 hours.
None Documented
None Documented
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function, prolonged in renal impairment.
Approximately 0.25-1.5 hours (15-90 minutes); prolonged in renal impairment or with mannitol accumulation (e.g., in anuria).
Renal: >90% excreted unchanged by glomerular filtration with minimal tubular reabsorption. Negligible biliary/fecal elimination.
Primarily renal (90-100% unchanged in urine); negligible biliary or fecal elimination.
Category C
Category C
Osmotic Diuretic
Osmotic Diuretic